Suppr超能文献

促肾上腺皮质激素肿瘤中血管加压素(V3)和促肾上腺皮质激素释放激素受体基因的过表达。

Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.

作者信息

de Keyzer Y, René P, Beldjord C, Lenne F, Bertagna X

机构信息

Groupe d'Etudes en Physiopathologie Endocrinienne, Université René Descartes, Paris, France.

出版信息

Clin Endocrinol (Oxf). 1998 Oct;49(4):475-82. doi: 10.1046/j.1365-2265.1998.00560.x.

Abstract

OBJECTIVE

The molecular mechanisms underlying ACTH-secreting tumour formation remain unknown. Transmembrane signalling pathways play an important role in several endocrine disorders including pituitary tumours. To investigate the role of the pituitary vasopressin (V3) receptor (R) in ACTH-secreting tumours we have qualitatively and quantitatively analysed its mRNA.

DESIGN

RT-PCR, denaturing gradient gel electrophoresis and S1 nuclease protection experiments were used to analyse V3 mRNA structure in ACTH-secreting tumours. We also developed a competitive RT-PCR system to compare the levels of expression of POMC, V3 and CRH-R genes. This system used as competitor a single mutant template (termed multi-mutant) containing primers for the three genes flanking an unrelated core sequence allowing multiple quantifications from the same cDNA preparations. We analysed 12 normal pituitaries, 15 corticotroph pituitary adenomas and 6 ACTH-secreting bronchial carcinoids.

RESULTS

The V3 mRNA structure and sequence were found to be identical in normal and tumoural pituitary indicating that the tumoural Vs mRNA codes for a normal receptor. POMC RT-PCR signals in the pituitary tumour group were approximately 7-fold higher than in the normal pituitary group. Similarly, V3 and CRH-R signal were increased in pituitary tumors (mean +/- SEM: 5.87 x 10(-6) +/- 1.73 x 10(-6), and 2.33 x 10(-4) +/- 1.4 x 10(-4), respectively), when compared to normal pituitaries (1.19 x 10(-7) +/- 2.39 x 10(-8), and 1.7 x 10(-6) +/- 4.65 x 10(-7), respectively) suggesting that these two genes are expressed at very high levels in corticotroph tumours. When expressed relative to the corresponding POMC signals, increases in V3 and CRH-R signals reached 49-fold and 137-fold, respectively, in pituitary tumours. In ACTH-secreting bronchial carcinoids V3 gene expression level was also higher than in normal pituitary, whereas CRH-R signals were detected in only 4 of the 6 tumours with wide variations.

CONCLUSION

Our results show that both vasopressin and CRH receptor genes are overexpressed in ACTH-secreting pituitary tumours. They suggest that overexpression of G protein-coupled receptors may be an additional mechanism through which membrane receptors may play a role in human tumours.

摘要

目的

促肾上腺皮质激素(ACTH)分泌性肿瘤形成的分子机制尚不清楚。跨膜信号通路在包括垂体瘤在内的多种内分泌疾病中起重要作用。为了研究垂体加压素(V3)受体(R)在ACTH分泌性肿瘤中的作用,我们对其mRNA进行了定性和定量分析。

设计

采用逆转录聚合酶链反应(RT-PCR)、变性梯度凝胶电泳和S1核酸酶保护实验分析ACTH分泌性肿瘤中V3 mRNA的结构。我们还开发了一种竞争性RT-PCR系统,以比较阿黑皮素原(POMC)、V3和促肾上腺皮质激素释放激素受体(CRH-R)基因的表达水平。该系统使用一个单一的突变模板(称为多突变体)作为竞争物,该模板包含三个基因的引物,其侧翼为无关的核心序列,允许从同一cDNA制剂中进行多次定量。我们分析了12个正常垂体、15个促肾上腺皮质激素细胞垂体腺瘤和6个ACTH分泌性支气管类癌。

结果

发现正常垂体和肿瘤垂体中V3 mRNA的结构和序列相同,表明肿瘤V3 mRNA编码一种正常受体。垂体肿瘤组的POMC RT-PCR信号比正常垂体组高约7倍。同样,与正常垂体相比(分别为1.19×10⁻⁷±2.39×10⁻⁸和1.7×10⁻⁶±4.65×10⁻⁷),垂体肿瘤中V3和CRH-R信号增加(分别为5.87×10⁻⁶±1.73×10⁻⁶和2.33×10⁻⁴±1.4×10⁻⁴),这表明这两个基因在促肾上腺皮质激素细胞肿瘤中表达水平非常高。当相对于相应的POMC信号表达时,垂体肿瘤中V3和CRH-R信号分别增加到49倍和137倍。在ACTH分泌性支气管类癌中,V3基因表达水平也高于正常垂体,而在检测的6个肿瘤中,只有4个检测到CRH-R信号,且差异较大。

结论

我们的结果表明,加压素和CRH受体基因在ACTH分泌性垂体肿瘤中均过度表达。它们提示G蛋白偶联受体的过度表达可能是膜受体在人类肿瘤中发挥作用的另一种机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验